THE PRIMER
SCIENCE MADE SIMPLE
Stay Updated! Subscribe to The Primer
Share
New Gene Therapy Drug Explained
In March 2023, Novartis’ (Basel, Switzerland), shared its latest data concerning Zolgensma. The findings reveal sustained durability up to 7.5 years post-dosing, with a 100% achievement of all assessed milestones in children treated before the onset of spinal muscular...
From Drug Discovery to Approval: Phase III
Our recent article explored the riskiest part of the human clinical trials pathway: Phase II. About 70% of drugs that enter Phase II never make it out. Most often, it’s because they fail to demonstrate effectiveness. Even making it to Phase III is no guarantee of...
Drug Commercialization Process: From Research to Market
The drug commercialization process is critical in bringing new pharmaceuticals to market. It involves a complex series of steps, from initial research and development to clinical trials, regulatory approval, and commercialization. For pharmaceutical companies, the...
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.